MC2142A1 - Medicament contre la toxoplasmose - Google Patents

Medicament contre la toxoplasmose

Info

Publication number
MC2142A1
MC2142A1 MC@@@@D MC2142D MC2142A1 MC 2142 A1 MC2142 A1 MC 2142A1 MC 2142 D MC2142 D MC 2142D MC 2142 A1 MC2142 A1 MC 2142A1
Authority
MC
Monaco
Prior art keywords
toxoplasmosis
prophylaxis
animal
compound
treatment
Prior art date
Application number
MC@@@@D
Other languages
English (en)
French (fr)
Inventor
Alan Thomas Hudson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC2142A1 publication Critical patent/MC2142A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MC@@@@D 1989-09-22 1989-10-26 Medicament contre la toxoplasmose MC2142A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898921516A GB8921516D0 (en) 1989-09-22 1989-09-22 Medicaments
PCT/GB1989/001286 WO1991004021A1 (en) 1989-09-22 1989-10-26 Medicaments for the treatment of toxoplasmosis

Publications (1)

Publication Number Publication Date
MC2142A1 true MC2142A1 (fr) 1992-02-18

Family

ID=10663513

Family Applications (1)

Application Number Title Priority Date Filing Date
MC@@@@D MC2142A1 (fr) 1989-09-22 1989-10-26 Medicament contre la toxoplasmose

Country Status (17)

Country Link
EP (1) EP0445141B1 (xx)
JP (1) JP2810746B2 (xx)
KR (1) KR920700626A (xx)
AT (1) ATE108063T1 (xx)
AU (1) AU628422B2 (xx)
CA (1) CA2001568C (xx)
DE (1) DE68916651T2 (xx)
DK (1) DK175716B1 (xx)
GB (1) GB8921516D0 (xx)
HU (1) HU207942B (xx)
IE (1) IE66153B1 (xx)
MC (1) MC2142A1 (xx)
MW (1) MW1291A1 (xx)
PH (1) PH27250A (xx)
SG (1) SG28346G (xx)
WO (1) WO1991004021A1 (xx)
ZA (1) ZA898146B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9224739D0 (en) 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
WO2010023686A2 (en) * 2008-08-29 2010-03-04 Matrix Laboratories Limited Crystalline form of 2-chloro-3-[4-(4-chlorophenyl) cyclohexyl] [1,4]naphthoquinone, process for the same and use for producing 2-[4-(4-chlorophenyl)cyclohexyl]-3- hydroxy- 1,4- naphthoquinone
US9169232B2 (en) * 2011-09-16 2015-10-27 Alkem Laboratories Limited 3-(5-methyl-2-oxo-l, 3-dioxol-4-yl) methyloxy-2-trans-[(4-chloro phenyl) cyclohexyl][1,4]naphthaquinone-atovaquone prodrug
CN104474416A (zh) * 2014-11-03 2015-04-01 青岛绿曼生物工程有限公司 治疗猪弓形体病的复方蜂胶组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
ATE178311T1 (de) * 1988-08-16 1999-04-15 Wellcome Found Neue naphthochinone und ihre anwendung als arzneimittel

Also Published As

Publication number Publication date
DE68916651D1 (de) 1994-08-11
IE893451A1 (en) 1991-03-27
AU628422B2 (en) 1992-09-17
CA2001568A1 (en) 1991-03-22
EP0445141B1 (en) 1994-07-06
ATE108063T1 (de) 1994-07-15
HUT57040A (en) 1991-11-28
DE68916651T2 (de) 1995-02-16
ZA898146B (en) 1991-06-26
HU207942B (en) 1993-07-28
DK93091D0 (da) 1991-05-16
IE66153B1 (en) 1995-12-13
WO1991004021A1 (en) 1991-04-04
DK93091A (da) 1991-06-28
AU4519189A (en) 1991-04-18
EP0445141A1 (en) 1991-09-11
GB8921516D0 (en) 1989-11-08
JP2810746B2 (ja) 1998-10-15
SG28346G (en) 1995-09-18
JPH04504107A (ja) 1992-07-23
DK175716B1 (da) 2005-01-31
CA2001568C (en) 1998-05-12
HU896916D0 (en) 1991-08-28
KR920700626A (ko) 1992-08-10
PH27250A (en) 1993-05-04
MW1291A1 (en) 1991-11-13

Similar Documents

Publication Publication Date Title
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
NO912414D0 (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
MC2142A1 (fr) Medicament contre la toxoplasmose
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
AR120931A1 (es) Fungicidas para prevenir y controlar patógenos fúngicos
MC2203A1 (fr) Medicament contre la cryptosporidiose
ES2105643T3 (es) Uso de la 2-(4-(4-clorofenil)ciclohexil)-3-hidroxi-1,4-naftoquinona para el tratamiento del cancer.
GB9126874D0 (en) Medicaments
ATE110714T1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
GEP19970834B (en) 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
RU2107502C1 (ru) Ветеринарный препарат, обладающий широким спектром действия, - йод однохлористый
HUT62474A (en) Process for producing veterinary composition with antiparasitic effect
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
KR890000089A (ko) 신장 질환 치료제

Legal Events

Date Code Title Description
PED Not yet granted